Filings For: CG Oncology, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
CG Oncology, Inc. (CGON) 11/6/2026 8:51:49 AM Mid View Financials 10-Q SEC 3Q 2026 ending: 9/30/2026 Rev: $1,604,000 -3.7% Assets $1,046,670,000 EPS -$0.64
CG Oncology, Inc. (CGON) 11/6/2026 8:31:35 AM   View Financials Earnings SEC 3Q 2026 Rev $1,604,000 -3.7% Assets $1,046,670,000 EPS -$0.64 Export Earnings Model
CG Oncology, Inc. (CGON) 8/6/2026 8:52:10 AM Mid View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Rev: $1,157,000 Assets $1,085,655,000 EPS -$0.90
CG Oncology, Inc. (CGON) 8/6/2026 8:31:16 AM   View Financials Earnings SEC 2Q 2026 Rev $1,157,000 Assets $1,085,655,000 EPS -$0.90 Export Earnings Model
CG Oncology, Inc. (CGON) 5/8/2026 4:25:02 PM Mid View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Rev: $1,083,000 +1,982.7% Assets $1,135,262,000 EPS -$0.71
CG Oncology, Inc. (CGON) 5/8/2026 8:46:17 AM   View Financials Earnings SEC 1Q 2026 Rev $1,083,000 +1,982.7% Assets $1,135,262,000 EPS -$0.71 Export Earnings Model
CG Oncology, Inc. (CGON) 4/24/2026 4:38:31 PM   View Proxy SEC Y 2025
CG Oncology, Inc. (CGON) 2/27/2026 9:16:33 AM Small View Financials 10-K SEC Y 2025 ending: 12/31/2025 Rev: $4,040,000 +254.7% Assets $791,592,000 EPS -$2.08
CG Oncology, Inc. (CGON) 2/27/2026 8:46:10 AM   View Financials Earnings SEC Y 2025 Rev $2,322,000 +409.2% Assets $791,592,000 EPS -$0.51 Export Earnings Model
CG Oncology, Inc. (CGON) 11/14/2025 4:35:13 PM Small View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Rev: $1,666,000 +3,774.4% Assets $729,913,000 EPS -$0.57
CG Oncology, Inc. (CGON) 11/14/2025 8:17:24 AM   View Financials Earnings SEC 3Q 2025 Rev $1,666,000 +3,774.4% Assets $729,913,000 EPS -$0.57 Export Earnings Model
CG Oncology, Inc. (CGON) 8/8/2025 4:22:20 PM Small View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Assets $701,445,000 EPS -$0.54
CG Oncology, Inc. (CGON) 8/8/2025 8:16:48 AM   View Financials Earnings SEC 2Q 2025 Rev $0 Assets $701,445,000 EPS -$0.54 Export Earnings Model
CG Oncology, Inc. (CGON) 5/13/2025 8:41:49 AM Small View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Rev: $52,000 -90.2% Assets $728,181,000 EPS -$0.45
CG Oncology, Inc. (CGON) 5/13/2025 8:16:06 AM   View Financials Earnings SEC 1Q 2025 Rev $52,000 -90.2% Assets $728,181,000 EPS -$0.45 Export Earnings Model
CG Oncology, Inc. (CGON) 4/25/2025 8:07:20 AM   View Proxy SEC Y 2024
CG Oncology, Inc. (CGON) 3/28/2025 9:06:32 AM Small View Financials 10-K SEC Y 2024 ending: 12/31/2024 Rev: $1,139,000 +458.3% Assets $754,797,000 EPS -$1.41
CG Oncology, Inc. (CGON) 3/28/2025 7:16:46 AM   View Financials Earnings SEC Y 2024 Rev $456,000 +45,500.0% Assets $754,797,000 EPS -$0.48 Export Earnings Model
CG Oncology, Inc. (CGON) 11/12/2024 9:43:40 AM Small View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Rev: $43,000 +377.8% Assets $552,471,000 EPS -$0.30
CG Oncology, Inc. (CGON) 11/12/2024 9:31:41 AM   View Financials Earnings SEC 3Q 2024 Rev $43,000 +377.8% Assets $552,471,000 EPS -$0.30 Export Earnings Model
CG Oncology, Inc. (CGON) 8/8/2024 6:38:24 AM Small View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Rev: $111,000 Assets $564,330,000 EPS -$0.28
CG Oncology, Inc. (CGON) 8/8/2024 6:20:00 AM   View Financials Earnings SEC 2Q 2024 Rev $111,000 Assets $564,330,000 EPS -$0.28 Export Earnings Model
CG Oncology, Inc. (CGON) 5/9/2024 8:12:27 AM   View Financials Earnings SEC 1Q 2024 Rev $529,000 +172.7% Assets $579,108,000 EPS -$0.36 Export Earnings Model
CG Oncology, Inc. (CGON) 5/9/2024 6:18:01 AM Small View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Rev: $529,000 +172.7% Assets $579,108,000 EPS -$0.36